Investors
Invus
https://invus.comInvus is a venture capital fund managing over $8 billion, with offices in New York, Paris, Singapore, and Hong Kong. They specialize in biotech and health tech, investing in later stages of company growth. Notable investments include Achilles Therapeutics and Sensorion. Their evergreen structure allows for a long-term investment horizon, supporting sustained growth and development in transformative healthcare businesses.
Recent Investments
- KNIMESeries B( 46 )
- SensorionSeries B( 41 )
- Achilles TherapeuticsSeries C( 60 )
- Achilles TherapeuticsSeries B( 60 )